p53: oncogene or anti-oncogene

David P Lane, Sam Benchimol
1990-01-01
Abstract:The products of two groups of DNA tumor viruses bind p53 p53, a 375-amino-acid nuclear phosphoprotein, was first detected because it formed a tight complex with the SV40 large-T antigen (Lane and Crawford 1979; Linzer and Levine 1979) and therefore was coimmunoprecipitated with anti-T antibodies from extracts of SV40-transformed cells. This observation revealed the first example of such a complex between a viral oncogene and a host protein and served as a precedent for the discovery of a large number of protein-protein interactions between the products of oncogenes and other proteins. For example, other polyomavirus large-T antigens, including the BK, JC, and LPV proteins, but not the polyomavirus protein, were also found to complex with p53. Of intense interest was the finding that the adenovirus 5 58,000-kD E1B protein also bound p53 (Sarnow et al. 1982). Because the E1B gene product cooperates with the E1A gene product in cell transformation, but shows no obvious homology to SV40 large-T antigen, this result suggested that the transforming proteins of these two distinct DNA tumor virus families were targeting the same host protein as part of their transforming action. This idea has been greatly enhanced by recent work on the retinoblastoma (Rb) gene. Like p53, the retinoblastoma protein pl05-Rb is physically complexed to the oncogene products of different groups of DNA tumor viruses. The adenovirus E1A (Whyte et al. 1988) proteins, the polyomavirus large-T antigens (DeCaprio et al. 1988), and the human papillomavirus E7 proteins (Dyson et al. 1989) all bind Rb through conserved sequence motifs. This conservation …
What problem does this paper attempt to address?